UK Chronic Lymphocytic Leukaemia (CLL) Forum (@ukcllforum) 's Twitter Profile
UK Chronic Lymphocytic Leukaemia (CLL) Forum

@ukcllforum

A UK group of physicians and patients committed to improve #CLL care and providing education about CLL in the UK ukcllforum.org

ID: 1176558073932144642

calendar_today24-09-2019 18:04:50

311 Tweet

1,1K Followers

26 Following

iwCLL (@iwcll) 's Twitter Profile Photo

Join us in Kraków, Poland on 12–15 September 2025 for #iwcLL2025. Attendees will learn about cutting-edge research in #CLL and debate the practical management of patients with CLL, all while networking to advance the field of CLL. Register today: loom.ly/KSNFwRg

Join us in Kraków, Poland on 12–15 September 2025 for #iwcLL2025.

Attendees will learn about cutting-edge research in #CLL and debate the practical management of patients with CLL, all while networking to
advance the field of CLL.

Register today: loom.ly/KSNFwRg
UK Chronic Lymphocytic Leukaemia (CLL) Forum (@ukcllforum) 's Twitter Profile Photo

Publication Alert - UK CLL Study Group IMPROVE trial, led by Dr. Helen Parry Important data on the role of brief introductions of BTKi on response to COVID (an other) vaccines. Great collaborative UK work. #CLL sciencedirect.com/science/articl…

Publication Alert - UK CLL Study Group

IMPROVE trial, led by Dr. Helen Parry
Important data on the role of brief introductions of BTKi on response to COVID (an other) vaccines.
Great collaborative UK work.
#CLL

sciencedirect.com/science/articl…
UK Chronic Lymphocytic Leukaemia (CLL) Forum (@ukcllforum) 's Twitter Profile Photo

The UK Chronic Lymphocytic Leukaemia (CLL) Forum spring newsletter is now live in our website. Excellent summary of the talks fo the annual scientific day - special mention to Catovsky Prize winner Ms Vitoria Pereira for her abstract on ibrutinib-based therapy on the T-cell compartment in CLL.

UK Chronic Lymphocytic Leukaemia (CLL) Forum (@ukcllforum) 's Twitter Profile Photo

Great success of the UK Chronic Lymphocytic Leukaemia (CLL) Forum session at #BSH2025. Many thanks to Prof Paul Moss, Prof Martin Dyer and Dima El-Sharkawi for their valuable, insightful and engaging talks. See you in October in our Clinical Sciences meeting.

Great success of the <a href="/UkCllforum/">UK Chronic Lymphocytic Leukaemia (CLL) Forum</a> session at #BSH2025.

Many thanks to Prof Paul Moss, Prof Martin Dyer and Dima El-Sharkawi for their valuable, insightful and engaging talks.

See you in October in our Clinical Sciences meeting.
UK Chronic Lymphocytic Leukaemia (CLL) Forum (@ukcllforum) 's Twitter Profile Photo

Colleagues from Lymphoma Hub have published the top #EHA25 abstracts. FLAIR in the spotlight, alongside final analysis of CLL13 trial. Great read if you have missed EHA. EHA 2025 | Top abstracts in Lymphoma and CLL #CLL

iwCLL (@iwcll) 's Twitter Profile Photo

#iwCLL2025 in Kraków, Poland, is a few weeks away! Engage with cutting-edge insights, collaborate to advance patient management, and foster connections that fuel progress in the field. Sign up today: loom.ly/KSNFwRg

#iwCLL2025 in Kraków, Poland, is a few weeks away!

Engage with cutting-edge insights, collaborate to advance patient management, and foster connections that fuel progress in the field.

Sign up today: loom.ly/KSNFwRg
VJHemOnc (@vjhemonc) 's Twitter Profile Photo

🎙️ The first episode of our #BloodCancerAwarenessMonth podcast special is here! Experts answer YOUR questions on #CLL, #myeloma & #lymphoma 🔬✨ Featuring Barbara Eichhorst, Rakesh Popat & Anna Sureda. 👉 Listen now: ow.ly/v48L50WVPEP Stay tuned for next week’s

🎙️ The first episode of our #BloodCancerAwarenessMonth podcast special is here!

Experts answer YOUR questions on #CLL, #myeloma &amp; #lymphoma 🔬✨

Featuring Barbara Eichhorst, <a href="/DrRakeshPopat/">Rakesh Popat</a> &amp; <a href="/AnnaSureda5/">Anna Sureda</a>.

👉 Listen now: ow.ly/v48L50WVPEP

Stay tuned for next week’s
VJHemOnc (@vjhemonc) 's Twitter Profile Photo

Thank you to Matthew Davids, MD, MMSc (Dana-Farber) for catching up with us today at #iwCLL2025!😁 We heard about: 👉 the SOUNDTRACK-E & MAVRiC trials 👉 a tandem CD19/ROR1 CAR-NK in CLL 👉 the recently published consensus report on monoclonal B-cell lymphocytosis You won't want to miss this

Thank you to <a href="/DrMDavids/">Matthew Davids, MD, MMSc</a> (<a href="/DanaFarber/">Dana-Farber</a>) for catching up with us today at #iwCLL2025!😁

We heard about:
👉 the SOUNDTRACK-E &amp; MAVRiC trials
👉 a tandem CD19/ROR1 CAR-NK in CLL
👉 the recently published consensus report on monoclonal B-cell lymphocytosis

You won't want to miss this
VJHemOnc (@vjhemonc) 's Twitter Profile Photo

🎥 Earlier today, Kerry Rogers of Ohio State Hematology provided valuable insight into her talk at #iwCLL2025 on targeting surface antigens in CLL. Dr Rogers also discussed the management of double-refractory disease.🩸 Keep an eye out on our site for the full interview soon!

🎥 Earlier today, <a href="/KerryARogersMD/">Kerry Rogers</a> of <a href="/OSUHematology/">Ohio State Hematology</a>  provided valuable insight into her talk at #iwCLL2025 on targeting surface antigens in CLL. Dr Rogers also discussed the management of double-refractory disease.🩸

Keep an eye out on our site for the full interview soon!
VJHemOnc (@vjhemonc) 's Twitter Profile Photo

We've just kicked off our second day at #iwCLL2025!🩸😁 It was great to hear from Chris Pepper of BSMS, who shared insight into the development of novel strategies targeting the NF-κB signaling pathway in CLL, including a first-in-class PROTAC. #CLLsm #Leusm

We've just kicked off our second day at #iwCLL2025!🩸😁

It was great to hear from <a href="/ChrisPepper64/">Chris Pepper</a> of <a href="/BSMSMedSchool/">BSMS</a>, who shared insight into the development of novel strategies targeting the NF-κB signaling pathway in CLL, including a first-in-class PROTAC.

#CLLsm #Leusm
VJHemOnc (@vjhemonc) 's Twitter Profile Photo

It was a pleasure to catch up with Talha Munir (Leeds Teaching Hospitals), who discussed several of his interesting posters at #iwCLL2025. Don't miss the full interview to hear about: 🩸the PhIII STATIC trial 🩸a report of the FLAIR trial 🩸an MAIC of zanu vs fixed-duration AV for 1L CLL

It was a pleasure to catch up with Talha Munir (<a href="/LeedsHospitals/">Leeds Teaching Hospitals</a>), who discussed several of his interesting posters at #iwCLL2025.

Don't miss the full interview to hear about:
🩸the PhIII STATIC trial
🩸a report of the FLAIR trial
🩸an MAIC of zanu vs fixed-duration AV for 1L CLL
VJHemOnc (@vjhemonc) 's Twitter Profile Photo

The wonderful Barbara Eichhorst of Universität zu Köln stopped by to share the 2-year follow-up results from the Phase Ib/II EPCORE CLL-1 trial, and to discuss the frontline treatment of CLL.🩸 Catch this interview, and many more from #iwCLL2025, on VJHemOnc.com soon!🎥

The wonderful Barbara Eichhorst of <a href="/UniCologne/">Universität zu Köln</a> stopped by to share the 2-year follow-up results from the Phase Ib/II EPCORE CLL-1 trial, and to discuss the frontline treatment of CLL.🩸

Catch this interview, and many more from #iwCLL2025, on VJHemOnc.com soon!🎥
VJHemOnc (@vjhemonc) 's Twitter Profile Photo

Watch our insightful interview from #iwCLL2025, in which Alexey Danilov (Danilov Lab) of City of Hope discusses the emerging promise of targeted protein degraders in CLL and other heme malignancies: 👉 ow.ly/1LEL50WY3Ki 👈 #CLLsm #Leusm #Leukemia #HemOnc

UK Chronic Lymphocytic Leukaemia (CLL) Forum (@ukcllforum) 's Twitter Profile Photo

🚨Followers. UK Chronic Lymphocytic Leukaemia (CLL) Forum clinical science day is fast approaching. 3rd of October 2025 at the Cavendish conference centre-London. Featuring parallel CLL nurse forum meeting in collaboration with Leukaemia Care Still time to register!

🚨Followers.
<a href="/UkCllforum/">UK Chronic Lymphocytic Leukaemia (CLL) Forum</a> clinical science day is fast approaching.
3rd of October 2025 at the Cavendish conference centre-London.

Featuring parallel CLL nurse forum meeting in collaboration with <a href="/LeukaemiaCareUK/">Leukaemia Care</a> 

Still time to register!